# US Vascular Closure Devices Market

> US Vascular Closure Devices Market Research Report: Size, Share, Trend Analysis By Product Type (Passive Vascular Closure Device, Active Vascular Closure Device, External Hemostatic Device), By Access (Femoral, Radial), By Procedures (Interventional Cardiology, Interventional Radiology) and By Applications (Diagnostic, Therapeutic) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.88%
- **2024:** $ 367.5 Million
- **2025:** $ 400.13 Million
- **2035:** $ 937.25 Million
- **Key Players:** Abbott Laboratories (US), Medtronic (US), Terumo Corporation (JP), Boston Scientific Corporation (US), Cardinal Health (US), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Vascular Solutions, Inc. (US)

**Report ID:** MRFR/MED/14020-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-vascular-closure-devices-market-15547

---

## Market Summary

## **US Vascular Closure Devices Market Overview**

As per MRFR analysis, the US Vascular Closure Devices Market Size was estimated at 338.1 (USD Million) in 2023. The US Vascular Closure Devices Market Industry is expected to grow from 367.5(USD Million) in 2024 to 847.64 (USD Million) by 2035. The US Vascular Closure Devices Market CAGR (growth rate) is expected to be around 7.894% during the forecast period (2025 - 2035).

### **Key US Vascular Closure Devices Market Trends Highlighted**

The US Vascular Closure Devices Market is experiencing several significant trends driven by its healthcare landscape. One of the key market drivers is the rising prevalence of cardiovascular diseases within the country, prompting healthcare providers to seek innovative and effective solutions for vascular access. Additionally, the increasing number of diagnostic and therapeutic procedures, such as catheterizations, fuels the demand for vascular closure devices, as they play a crucial role in minimizing complications like bleeding and promoting faster recovery times for patients.

Opportunities in this market are vast, particularly with the ongoing advancements in technology.The development of minimally invasive procedures has created a favorable environment for deploying innovative vascular closure devices that are user-friendly and effective. The integration of smart technologies, such as devices that provide feedback to clinicians during procedures, is another avenue to explore, enhancing safety and efficiency. Recent trends indicate a growing shift towards device personalization and the customization of solutions to suit specific patient needs.

As healthcare systems focus on delivering high-quality patient care, manufacturers are increasingly emphasizing the development of products that cater to diverse anatomical variations and clinical scenarios.Furthermore, the ongoing focus on reducing hospital stay durations and recovery times is driving hospitals in the US to adopt these devices more extensively, aligning with broader healthcare objectives. Overall, the combination of technological advancements, rising procedural demands, and a patient-centered approach is shaping the evolution of the US Vascular Closure Devices Market significantly.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Vascular Closure Devices Market Drivers**

### **Increasing Prevalence of Cardiovascular Diseases**

The US Vascular Closure Devices Market Industry is witnessing significant growth driven by the increasing prevalence of cardiovascular diseases (CVDs). According to the Centers for Disease Control and Prevention (CDC), CVDs affect nearly 697,000 people in the US annually, accounting for about 1 in every 5 deaths. This high incidence rate underscores the demand for surgical interventions and, consequently, the need for vascular closure devices that facilitate faster recovery times and minimize complications.

Organizations such as the American Heart Association (AHA) are actively promoting awareness and research, thereby influencing innovations and advancements in vascular closure devices. As the healthcare sector continues to prioritize heart health, the market's growth trajectory will likely remain strong in response to the rising CVD patient population, ensuring an ongoing need for effective vascular management solutions.

### **Technological Advancements in Medical Devices**

The advancement of technology in medical devices is acting as a significant catalyst for the US Vascular Closure Devices Market Industry. With innovations such as bioabsorbable materials and enhanced delivery systems, the efficacy of vascular closure devices has markedly improved. The Food and Drug Administration (FDA) has been proactive in approving various cutting-edge devices that reflect these advancements. For example, devices that utilize hemostatic mechanisms to optimize closure have gained traction in both clinical and outpatient settings.

As per the FDA, the rapid pace of innovation is expected to pave the way for new entrants and enhance current offerings, thus boosting the market's growth. The US's emphasis on Research and Development in healthcare technology plays a pivotal role in advancing patient outcomes and expanding the vascular closure market landscape.

### **Growing Geriatric Population**

The aging demographic in the US is poised to have a considerable impact on the US Vascular Closure Devices Market Industry. The U.S. Census Bureau projects that by 2030, approximately 20% of the US population will be aged 65 or older, representing over 73 million individuals. This demographic is particularly susceptible to conditions requiring surgical interventions, such as angioplasties and catheterizations. The National Institute on Aging reports that older adults often experience multiple comorbidities that necessitate vascular procedures.

As healthcare providers focus on catering to the specialized needs of the geriatric population, the demand for effective and efficient vascular closure devices is set to rise significantly. The active involvement of the AARP (formerly known as the American Association of Retired Persons) is also crucial in advocating for innovations and standards to improve care for this expanding group.

## **US Vascular Closure Devices Market Segment Insights**

### **Vascular Closure Devices Market Product Type Insights**

The US[Vascular Closure Devices](../../../reports/vascular-closure-devices-market-5704) Market is a growing sector that plays a significant role in improving patient outcomes during and after vascular procedures. The Product Type segmentation of this market includes Passive Vascular Closure Devices, Active Vascular Closure Devices, and External Hemostatic Devices, each serving distinct yet vital functions in clinical settings. Passive Vascular Closure Devices are particularly notable for their simplicity and effectiveness, as they rely on natural physiological mechanisms to achieve hemostasis, thereby reducing procedural time and minimizing complications.

In contrast, Active Vascular Closure Devices utilize mechanical or other active means to enhance hemostatic effectiveness, offering advantages in specific procedural scenarios where immediate closure is paramount. This active component is essential in complex procedures, indicating their importance in emergency and high-risk situations. External Hemostatic Devices, on the other hand, offer an adjunctive approach for controlling bleeding, often used in combination with other closure strategies; their significance lies in their versatility and the ability to be applied non-invasively.

The increasing prevalence of cardiovascular diseases and the growing number of interventional procedures are driving the market growth, as healthcare providers continuously seek to enhance procedural efficacy and patient safety. Innovations in technology and materials are evolving the design and functionality of these products, leading to improved performance and outcomes. Furthermore, with the rise of outpatient procedures, the demand for efficient and effective vascular closure solutions has surged, establishing a solid trajectory for future growth within the Product Type segment of the US Vascular Closure Devices Market.

This interest in various closure methods stems from a mix of factors, including patient preferences for less invasive solutions and the emphasis on cost-effective clinical practices in the US healthcare landscape. The interplay among these sub-segments highlights a robust and competitive market environment, ensuring that advancements in Vascular Closure Devices continue to align with the demands of modern medicine.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Vascular Closure Devices Market Access Insights**

The Access segment of the US Vascular Closure Devices Market represents a critical area as it facilitates safe and efficient access during catheterization procedures. Dominant access approaches, especially the Femoral and Radial methods, play significant roles in enhancing procedural outcomes. The Femoral access route has historically been preferred due to its reliability in achieving vascular access for diagnostics and interventions; however, the Radial approach has gained traction due to its association with reduced complications and shorter recovery times.

Factors driving growth within this segment include an increasing prevalence of cardiovascular diseases, the aging US population, and advancements in technology that improve device efficiency and safety. Additionally, healthcare professionals are increasingly prioritizing patient comfort and recovery, contributing to the growing preference for radial access. The market dynamics are also influenced by ongoing Research and Development initiatives aimed at innovating vascular closure solutions and improving procedural techniques, ensuring that the Access segment remains pivotal in the US Vascular Closure Devices Market.

As procedural volumes rise, the importance of effective vascular access strategies will continue to shape the landscape in this segment.

### **Vascular Closure Devices Market Procedures Insights**

The US Vascular Closure Devices Market Procedures segment has been experiencing significant growth, driven by increasing prevalence of cardiovascular diseases and advancements in minimally invasive procedures. Within this segment, Interventional Cardiology plays a crucial role as it addresses coronary artery disease and related conditions, allowing for faster recovery times and reduced hospital stays. The growing geriatric population and rising adoption of cardiac surgeries significantly contribute to this part of the market.

Similarly, Interventional Radiology holds a prominent position in the Procedures segment, offering effective treatment options for a variety of conditions through image-guided techniques which enhance accuracy and minimize risks.These trends highlight the increasing reliance on vascular closure devices in both specialties, with crucial implications for improving patient outcomes and healthcare efficiency. The ongoing innovation in device technology and methodologies promises to solidify the significance of these procedures within the US Vascular Closure Devices Market, catering to the evolving needs of healthcare professionals and patients alike.

As a result, the Procedures segment is poised for substantial expansion, reflecting the broader dynamics of the market driven by clinical advancements and rising demand for effective vascular interventions.

### **Vascular Closure Devices Market Application Insights**

The US Vascular Closure Devices Market, particularly in the Application segment, encompasses both Diagnostic and Therapeutic uses, reflecting the market's diverse functionalities and increasing demand. In the Diagnostic area, vascular closure devices are crucial for post-procedural closure, ensuring minimal complications and enhancing patient recovery. This segment is expected to leverage technological advancements in design and materials, which play a vital role in improving procedural outcomes.

On the other hand, the Therapeutic Application segment addresses the critical need for effective intervention in various cardiovascular conditions, significantly influencing treatment protocols.The growth within this segment is driven by the rising prevalence of vascular diseases in the United States, further supported by an increasing focus on minimally invasive procedures. The overall trend indicates a robust integration of innovative solutions that cater to both diagnostic evaluations and therapeutic requirements, promising efficient patient management.

As the healthcare industry in the US continues to evolve, these applications stand as pivotal components of the Vascular Closure Devices Market, making significant contributions to healthcare outcomes and operational efficiency.

## **US Vascular Closure Devices Market Key Players and Competitive Insights**

The competitive insights of the US Vascular Closure Devices Market reveal a dynamic landscape characterized by rapid technological advancements and an increasing focus on patient outcomes. This market is defined by a variety of players ranging from established corporations to emerging startups, each vying for market share through innovations in product design, efficacy, and safety. Vascular closure devices are critical tools used to minimize complications and accelerate recovery post-intervention for various vascular procedures, making their competitiveness crucial in hospital settings and for outpatient procedures.

The competitive environment is also shaped by evolving regulatory standards, advancements in minimally invasive techniques, and an increasing aging population that necessitates improved vascular care. Companies are continuously investing in research and development to enhance their offerings while monitoring market trends to address the changing healthcare demands.

Teleflex has established a significant presence in the US Vascular Closure Devices Market through its commitment to innovation and quality. The company's strength lies in its diverse portfolio of vascular closure products, which are designed to improve safety and efficiency in hemostasis after catheterization procedures. Teleflex's products are known for their reliability, ease of use, and minimal complication rates, which have garnered trust among clinicians and healthcare professionals.

Furthermore, Teleflex has built strong relationships with various healthcare institutions, allowing for widespread adoption of its devices across the United States. The company leverages its extensive experience and robust manufacturing capabilities to remain competitive in this evolving market, continuously pushing for enhancements in their product offerings and expanding its presence through strategic marketing and educational initiatives targeted at healthcare providers.

Imperial Medical is also a notable player in the US Vascular Closure Devices Market, focusing on delivering innovative solutions designed for improved patient outcomes. The company specializes in several key products that aim to simplify the vascular closure process while ensuring robust performance and decreased risk of complications. With a strategic presence in the market, Imperial Medical emphasizes customer engagement and feedback, utilizing these insights to refine its product development continually.

The company is also known for its collaborative approach, which includes partnerships, mergers, and acquisitions aimed at enhancing its technological capabilities and expanding its product portfolio. This positioning allows Imperial Medical to respond swiftly to market needs while maintaining a competitive edge through improved offerings and services tailored specifically for the US healthcare sector.

### Key Companies in the US Vascular Closure Devices Market Include:

## **US Vascular Closure Devices Market Industry Developments**

In recent months, the US Vascular Closure Devices Market has experienced notable developments, particularly with companies such as Teleflex, Terumo Corporation, and Abbott Laboratories driving innovation within the sector. In September 2023, Medtronic launched a next-generation vascular closure device aimed at improving patient outcomes and decreasing complication rates. This launch underscores the ongoing technological advancements in the market.

Furthermore, reports indicate Boston Scientific is actively exploring strategic partnerships to enhance its product offerings, while Merit Medical Systems announced plans to expand its manufacturing capabilities in the US to meet increasing demand. In terms of mergers and acquisitions, Teleflex completed its acquisition of a vascular access company in August 2023, enhancing its portfolio in the closure device segment. Similarly, Cardinal Health announced in July 2023 a merger with a healthcare technology firm to integrate advanced solutions for vascular procedures.

The market's valuation has continued to rise, reflecting an increasing prevalence of cardiovascular diseases in the US and a growing patient population undergoing interventional procedures. This factors into the ongoing demand for advanced vascular closure solutions to enhance surgical efficiency and improve patient safety.

## **US Vascular Closure Devices Market Segmentation Insights**

### **Vascular Closure Devices Market Product Type Outlook**

### **Vascular Closure Devices Market Access Outlook**

### **Vascular Closure Devices Market Procedures Outlook**

### **Vascular Closure Devices Market Application Outlook**

## Market Drivers

### Technological Innovations in Device Design

Technological advancements in the design and functionality of vascular closure devices are significantly influencing the market. Innovations such as bioresorbable materials, advanced suturing techniques, and improved delivery systems are enhancing the efficacy and safety of these devices. The introduction of devices that minimize the risk of complications, such as hematomas and infections, is particularly appealing to healthcare providers. As of 2025, The market is witnessing a shift towards devices that offer faster recovery times and improved patient comfort. The integration of digital technologies, such as real-time monitoring and data analytics, further supports the growth of this market segment. This trend indicates a robust future for the vascular closure-devices market, as manufacturers continue to invest in research and development to meet evolving clinical needs.

### Growing Preference for Outpatient Procedures

The shift towards outpatient procedures is reshaping the landscape of the vascular closure-devices market. As healthcare systems aim to reduce costs and improve patient throughput, many vascular interventions are now performed in outpatient settings. This trend is driven by advancements in minimally invasive techniques, which allow for quicker recovery and reduced hospital stays. The market is likely to benefit from this shift, as effective closure solutions are essential for ensuring patient safety and satisfaction in outpatient settings. Reports suggest that outpatient procedures are expected to grow by approximately 20% annually, further propelling the demand for reliable closure devices. This evolving preference indicates a promising trajectory for the vascular closure-devices market, as healthcare providers adapt to changing patient care models.

### Increased Focus on Patient Safety and Outcomes

The emphasis on patient safety and improved clinical outcomes is a critical driver for the vascular closure-devices market. Healthcare providers are increasingly prioritizing devices that not only facilitate effective closure but also minimize complications and enhance recovery. Regulatory bodies are also advocating for stringent safety standards, which further influences device development. The market is responding to this demand by introducing products that demonstrate superior performance in clinical settings. As hospitals and clinics strive to meet quality benchmarks, the adoption of advanced closure devices is likely to rise. This focus on safety and outcomes is expected to contribute to a market growth rate of around 15% over the next few years, reflecting the industry's commitment to enhancing patient care.

### Rising Investment in Healthcare Infrastructure

The ongoing investment in healthcare infrastructure across the US is a significant driver for the vascular closure-devices market. As hospitals and surgical centers expand their capabilities, the demand for advanced medical devices, including vascular closure solutions, is likely to increase. Government initiatives aimed at improving healthcare access and quality are also contributing to this trend. The market stands to benefit from these investments, as healthcare facilities seek to equip themselves with the latest technologies to provide optimal patient care. With an estimated $200 billion allocated for healthcare infrastructure improvements in the coming years, the market for vascular closure devices is poised for substantial growth. This influx of funding may lead to enhanced research and development efforts, further propelling innovation within the vascular closure-devices market.

### Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases in the US is a primary driver for the vascular closure-devices market. As the population ages, the prevalence of conditions such as coronary artery disease and peripheral artery disease increases, necessitating more interventional procedures. According to the American Heart Association, cardiovascular diseases account for approximately 1 in every 4 deaths in the US. This alarming statistic underscores the need for effective vascular closure solutions post-procedure. The market is expected to grow as healthcare providers seek to enhance patient outcomes and reduce complications associated with traditional closure methods. With an estimated market value projected to reach $1.5 billion by 2026, the demand for innovative closure devices is likely to surge, driven by the need for efficient and safe vascular interventions.

## Future Outlook

The [Vascular Closure Devices Market](https://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704) vascular closure-devices market is projected to grow at an 8.88% CAGR from 2025 to 2035, driven by technological advancements, increasing patient populations, and rising demand for minimally invasive procedures.

**New opportunities:**

- Development of biodegradable vascular closure devices for enhanced patient safety. Expansion into telehealth solutions for remote monitoring of closure device performance. Partnerships with hospitals for exclusive supply agreements on innovative closure technologies.

By 2035, the vascular closure-devices market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type: Passive Closure Devices (Largest) vs. Active Closure Devices (Fastest-Growing)

In the US vascular closure-devices market, Passive Closure Devices currently lead the market share due to their widespread acceptance and proven efficacy. They account for the largest proportion of the segment, preferred for their simplicity and reliability. On the other hand, Active Closure Devices are gaining traction as they integrate advanced technology, being preferred in more complex procedures, contributing to a growing share as hospitals and clinics adopt these innovative solutions.

Growth trends indicate a marked increase in the adoption of Active Closure Devices, driven by technological advancements, increased procedural volumes, and the rising demand for minimally invasive surgical techniques. As healthcare providers focus on enhancing patient outcomes and reducing recovery times, these devices are projected to see a significant surge in utilization. Additionally, the ongoing development of novel suturing techniques and materials is expected to bolster the market further.

Closure Devices: Passive (Dominant) vs. Active (Emerging)

Passive Closure Devices, characterized by their ease of use and effectiveness, remain dominant in the US vascular closure-devices market. These devices typically require minimal training for medical staff, making them a preferred choice in many clinical settings. They are often employed in standard procedures, ensuring reliable closure with low complication rates. In contrast, Active Closure Devices, featuring advanced mechanisms and technologies, represent the emerging segment. These devices offer greater control and quicker closure times, appealing to surgical teams aiming for enhanced performance in complex procedures. As innovations accelerate, both segments are vital; however, Active Closure Devices are increasingly recognized for their potential to revolutionize procedural standards.

### By Procedure Type: Transvascular Procedures (Largest) vs. Peripheral Procedures (Fastest-Growing)

In the US vascular closure-devices market, Transvascular Procedures command the largest share, underscoring their established presence in clinical practice. These procedures have been well-integrated into standard treatments, leading to higher adoption rates among healthcare providers. Peripheral Procedures, while currently smaller in share, are gaining increased traction due to their effectiveness in treating a diverse range of vascular conditions, driving their growing popularity.

The growth trends for these segments are closely tied to advancements in medical technology and increasing prevalence of vascular diseases. Transvascular Procedures are expected to continue dominating the market as innovations enhance their safety and efficacy. Conversely, Peripheral Procedures are identified as the fastest-growing segment, propelled by rising patient demand for minimally invasive treatment options and enhanced care outcomes, which attract more healthcare investments and focus on this area.

Transvascular Procedures (Dominant) vs. Peripheral Procedures (Emerging)

Transvascular Procedures hold a dominant position in the US vascular closure-devices market, characterized by their extensive usage in cardiac procedures and interventional therapies. Their well-established techniques and superior outcomes make them the preferred choice among health professionals. In contrast, Peripheral Procedures are emerging with significant potential, driven by enhanced device technologies and favorable clinical outcomes. This segment addresses the growing need for minimally invasive solutions for peripheral vascular conditions, which is attracting increasing recognition and investment from practitioners and manufacturers alike. The landscape is shifting as emerging technologies in Peripheral Procedures promise to improve patient experiences and results, thereby asserting their place as a competitive player in the evolving market.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

The US vascular closure-devices market exhibits a diverse distribution among its key end user segments. Hospitals dominate this landscape, capturing a significant market share due to their extensive surgical operations and the volume of vascular procedures conducted. Ambulatory Surgical Centers follow closely, gaining traction and market presence significantly in recent years. Specialty Clinics, while vital, remain a smaller segment, focusing on niche areas within vascular care, which limits their overall share in comparison to the larger entities.

Growth trends within this market segment are influenced by several factors, particularly the rising number of vascular surgeries and advancements in closure device technology. Hospitals are continuously investing in innovative solutions to enhance patient outcomes and minimize recovery times, boosting their market share. Conversely, Ambulatory Surgical Centers are experiencing rapid growth as procedural shifts toward outpatient care gain popularity, driven by patient demand for convenience and efficiency, marking them as a key growth driver in the sector.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals represent the dominant force in the US vascular closure-devices market, primarily due to their comprehensive capabilities and resources for managing complex vascular procedures. They leverage cutting-edge technologies and large patient volumes, ensuring a steady demand for closure devices. Ambulatory Surgical Centers, labeled as emerging players, are transforming the market by providing outpatient services with lower costs and enhanced patient experience. These centers are increasingly equipped with modern vascular closure technologies, catering to an evolving patient demographic that prefers less invasive, quick-discharge therapies. The strategic focus on improving efficiency and patient satisfaction positions them as strong contenders in the market's future.

### By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing)

In the US vascular closure-devices market, the distribution of sales channels reveals that Direct Sales constitute the largest segment, capturing a significant share due to established relationships with healthcare providers. Meanwhile, Online Sales are rapidly gaining traction, appealing to increasing demand for convenience and greater access to product information.

Growth trends indicate that while Direct Sales remain dominant driven by personalized service and reliability, Online Sales are the fastest-growing channel, fueled by technological advancements and a shift in purchasing behavior among clinicians. The rise of e-commerce in the medical sector reflects broader market dynamics, allowing smaller distributors and manufacturers to reach a wider audience.

Direct Sales (Dominant) vs. Online Sales (Emerging)

Direct Sales are characterized by strong personal relationships between vendors and healthcare professionals, ensuring product familiarity and trust. This channel tends to dominate due to its effectiveness in catering to the specific needs of medical facilities. Conversely, Online Sales present an emerging method, focusing on accessibility and convenience. This channel facilitates enhanced market reach and enables quicker transactions, appealing to tech-savvy practitioners. Both channels serve critical roles; however, Direct Sales maintain the advantage, while Online Sales are revolutionizing the purchasing landscape with innovative approaches.

## Competitive Benchmarking

The vascular closure-devices market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for minimally invasive procedures. Key players such as Abbott Laboratories (US), Medtronic (US), and Boston Scientific Corporation (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Abbott Laboratories (US) focuses on innovation, particularly in developing next-generation closure devices that improve patient outcomes. Meanwhile, Medtronic (US) emphasizes strategic partnerships and acquisitions to bolster its product portfolio and expand its market reach. Boston Scientific Corporation (US) is also heavily invested in digital transformation, integrating advanced technologies into its product offerings to streamline operations and enhance user experience. Collectively, these strategies contribute to a competitive environment that is increasingly centered around innovation and technological integration. The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several key players holding substantial market shares while also facing competition from emerging companies. This fragmentation allows for a diverse range of products and innovations, fostering a competitive atmosphere where established firms must continuously adapt to maintain their positions. In October 2025, Abbott Laboratories (US) announced the launch of a new vascular closure device designed to reduce recovery time for patients undergoing catheterization procedures. This strategic move is significant as it aligns with the growing trend towards faster recovery and improved patient experiences, potentially positioning Abbott as a leader in this niche segment of the market. The introduction of this device may also enhance Abbott's competitive edge by addressing specific patient needs and preferences. In September 2025, Medtronic (US) completed the acquisition of a smaller firm specializing in advanced closure technologies. This acquisition is likely to strengthen Medtronic's product offerings and expand its technological capabilities, allowing it to better compete against other major players. By integrating these new technologies, Medtronic may enhance its innovation pipeline and improve its market positioning. In August 2025, Boston Scientific Corporation (US) entered into a strategic partnership with a tech company to develop AI-driven solutions for vascular closure procedures. This collaboration suggests a forward-thinking approach, as the integration of AI could lead to more precise and efficient procedures, ultimately improving patient outcomes. Such partnerships may also reflect a broader trend in the industry towards leveraging technology to enhance product offerings and operational efficiencies. As of November 2025, the competitive trends in the vascular closure-devices market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and enhancing product development. Looking ahead, competitive differentiation is likely to evolve, shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may ultimately reshape the market landscape, compelling companies to invest in cutting-edge solutions that meet the evolving needs of healthcare providers and patients alike.

## Recent News & Developments

In recent months, the US Vascular Closure Devices Market has experienced notable developments, particularly with companies such as Teleflex, Terumo Corporation, and Abbott Laboratories driving innovation within the sector. In September 2023, Medtronic launched a next-generation vascular closure device aimed at improving patient outcomes and decreasing complication rates. This launch underscores the ongoing technological advancements in the market.

Furthermore, reports indicate Boston Scientific is actively exploring strategic partnerships to enhance its product offerings, while Merit Medical Systems announced plans to expand its manufacturing capabilities in the US to meet increasing demand. In terms of mergers and acquisitions, Teleflex completed its acquisition of a vascular access company in August 2023, enhancing its portfolio in the closure device segment. Similarly, Cardinal Health announced in July 2023 a merger with a healthcare technology firm to integrate advanced solutions for vascular procedures.

The market's valuation has continued to rise, reflecting an increasing prevalence of cardiovascular diseases in the US and a growing patient population undergoing interventional procedures. This factors into the ongoing demand for advanced vascular closure solutions to enhance surgical efficiency and improve patient safety.

## Report Scope

| MARKET SIZE 2024 | 367.5(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 400.13(USD Million) |
| MARKET SIZE 2035 | 937.25(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.88% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Abbott Laboratories (US), Medtronic (US), Terumo Corporation (JP), Boston Scientific Corporation (US), Cardinal Health (US), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Vascular Solutions, Inc. (US) |
| Segments Covered | Type, Procedure Type, End User, Distribution Channel |
| Key Market Opportunities | Advancements in minimally invasive techniques drive growth in the vascular closure-devices market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in vascular closure devices, enhancing patient outcomes and market competition. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US vascular closure-devices market?**
A: The market valuation was $367.5 Million in 2024.

**Q: What is the projected market size for the US vascular closure-devices market by 2035?**
A: The market is projected to reach $937.25 Million by 2035.

**Q: What is the expected CAGR for the US vascular closure-devices market during the forecast period 2025 - 2035?**
A: The expected CAGR is 8.88% during the forecast period.

**Q: Which segment had the highest valuation in the US vascular closure-devices market in 2024?**
A: Active Closure Devices had the highest valuation at $110.25 Million in 2024.

**Q: What are the projected valuations for Passive Closure Devices by 2035?**
A: Passive Closure Devices are projected to reach $182.75 Million by 2035.

**Q: Which procedure type is expected to generate the highest revenue in the US vascular closure-devices market?**
A: Transvascular Procedures are expected to generate the highest revenue, projected at $350.0 Million by 2035.

**Q: What is the expected market size for hospitals as an end user by 2035?**
A: The market size for hospitals as an end user is expected to reach $375.0 Million by 2035.

**Q: Which distribution channel is projected to have the highest valuation by 2035?**
A: Third-party Distributors are projected to have the highest valuation at $478.5 Million by 2035.

**Q: Who are the key players in the US vascular closure-devices market?**
A: Key players include Abbott Laboratories, Medtronic, Terumo Corporation, and Boston Scientific Corporation.

**Q: What is the projected valuation for Suture Closure Devices by 2035?**
A: Suture Closure Devices are projected to reach $245.625 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-vascular-closure-devices-market-15547*